Remarkable advances in biomedical research are leading to rapid growth and volatility in the biotechnology sector. An investment strategy rooted in deep analysis spanning public and private entities and using short sales to hedge against risk could help maximize return potential.
Please follow the download link to access the full Biotech whitepaper.
Download